Juan Miguel Cejalvo

机构：Instituto de Salud Carlos III, Hospital Clínico Universitario de Valencia, Centre for Biomedical Network Research on Rare Diseases, Solti, INCLIVA Health Research Institute, Centro de Investigación Biomédica en Red de Cáncer · ORCID：0000-0002-8755-8626

发表论文 256 篇 · 总被引 3554 次 · h-index 27

代表论文

• Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer (2025 · Clinical Cancer Research · 被引 3)
• Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO) (2026 · Nature Communications · 被引 2)
• Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial (2025 · ESMO Open · 被引 1)
• HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility (2026 · ESMO Open)
• Radioguided Surgery and Axillary Management in Breast Cancer: From Molecular Imaging to 3D Navigation Toward Personalized Treatment (2026 · Life)
• Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study (2026 · Breast Cancer Research)